Metformin does not improve survival in patients with hepatocellular carcinoma

doi:10.3748/wjg.v20.i42.15750

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 42

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5802)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

428

WORD

274

HTML

2979

Figures (1-1)

115

Tables (1-2)

104

Sum=3900

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1037

Download

865

Sum=1902

Nov 14, 2014 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (29)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Nov 14, 2014; 20(42): 15750-15755
Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15750

Open in New Tab Full Size Figure Download Figure

Figure 1 Kaplan-Meier survival curves of patients with hepatocellular carcinoma according to the following categories: (1) non-diabetics; (2) diabetics not on metformin; and (3) diabetics on metformin.

Citation: Bhat M, Chaiteerakij R, Harmsen WS, Schleck CD, Yang JD, Giama NH, Therneau TM, Gores GJ, Roberts LR. Metformin does not improve survival in patients with hepatocellular carcinoma. World J Gastroenterol 2014; 20(42): 15750-15755
URL: https://www.wjgnet.com/1007-9327/full/v20/i42/15750.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i42.15750